A detailed history of Enterprise Trust & Investment CO transactions in Abb Vie Inc. stock. As of the latest transaction made, Enterprise Trust & Investment CO holds 125 shares of ABBV stock, worth $21,627. This represents 0.01% of its overall portfolio holdings.

Number of Shares
125
Holding current value
$21,627
% of portfolio
0.01%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 22, 2022

BUY
$137.62 - $174.96 $17,202 - $21,870
125 New
125 $19,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $306B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Enterprise Trust & Investment CO Portfolio

Follow Enterprise Trust & Investment CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Enterprise Trust & Investment CO, based on Form 13F filings with the SEC.

News

Stay updated on Enterprise Trust & Investment CO with notifications on news.